⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Bromoethanol SCHEMBL13916048 | 0.80 | — | — | |
| 2-Bromoethanol SCHEMBL13916047 | 0.80 | — | — | |
| SCHEMBL1330915 | 0.79 | — | — | |
| SCHEMBL14477544 | 0.76 | — | — | |
| 1,2-Dibromoethane SCHEMBL1448860 | 0.72 | — | — | |
| Ethylene Glycol SCHEMBL2307225 | 0.72 | — | — | |
| SCHEMBL2832683 | 0.65 | — | — | |
| SCHEMBL4957834 | 0.65 | — | — | |
| SCHEMBL160013 | 0.65 | — | — | |
| Dibromomethane SCHEMBL20701 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10273203-B2 | Deuterated 3-methanesulfonylpropionitrile | OLATEC THERAPEUTICS LLC (US) | 2019-04-30 | — | — | US | claimed |
| US-20180290971-A1 | DEUTERATED 3-METHANESULFONYLPROPIONITRILE | OLATEC THERAPEUTICS, INC. | 2018-10-11 | — | — | US | claimed |
| EP-4615838-A1 | SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS | Merck Patent GmbH (DE) | 2025-09-17 | — | — | EP | disclosed |
| US-12325708-B2 | Adenosine 2 receptor antagonists | NEKTAR THERAPEUTICS (US) | 2025-06-10 | — | — | US | disclosed |
| WO-2024261234-A1 | DEUTERATED ANALOGS OF SIRTUIN 6 MODULATOR IMU-856 | IMMUNIC AG (DE) | 2024-12-26 | — | — | WO | disclosed |
| US-20240316059-A1 | PEPTIDE DRUG CONJUGATES | ONCOPEPTIDES AB (SE) | 2024-09-26 | — | — | US | disclosed |
| WO-2024099898-A1 | SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS | MERCK PATENT GMBH (DE) | 2024-05-16 | — | — | WO | disclosed |
| EP-4355370-A1 | PEPTIDE DRUG CONJUGATES | Oncopeptides Innovation AB (SE) | 2024-04-24 | — | — | EP | disclosed |
| CN-117794580-A | Polypeptide coupling medicine | 肿瘤多肽有限公司 | 2024-03-29 | — | — | CN | disclosed |
| WO-2022263679-A1 | PEPTIDE DRUG CONJUGATES | ONCOPEPTIDES AB (SE) | 2022-12-22 | — | — | WO | disclosed |
| US-20220235056-A1 | ADENOSINE 2 RECEPTOR ANTAGONISTS | NEKTAR THERAPEUTICS | 2022-07-28 | — | — | US | disclosed |
| EP-2222166-B9 | HETEROCYCLIC KINASE INHIBITORS | CONCERT PHARMACEUTICALS INC (US) | 2012-11-07 | — | — | EP | disclosed |
| EP-2222166-B1 | HETEROCYCLIC KINASE INHIBITORS | CONCERT PHARMACEUTICALS INC (US) | 2012-06-27 | — | — | EP | disclosed |
| WO-2012040138-A2 | NOVEL RADIOTRACER | GE HEALTHCARE LIMITED (GB) | 2012-03-29 | — | — | WO | disclosed |
| WO-2012040151-A2 | ISOTOPIC CARBON CHOLINE ANALOGS | GE HEALTHCARE LIMITED (GB) | 2012-03-29 | — | — | WO | disclosed |
| WO-2012040133-A2 | NOVEL PRECURSOR | GE HEALTHCARE LIMITED (GB) | 2012-03-29 | — | — | WO | disclosed |
| WO-2010033270-A1 | DIBENZOTHIAZEPINE MODULATORS OF DOPAMINE, ALPHA ADRENERGIC, AND SEROTONIN RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| US-20100069356-A1 | DIBENZOTHIAZEPINE MODULATORS OF DOPAMINE, ALPHA ADRENERGIC, AND SEROTONIN RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-03-18 | — | — | US | disclosed |
| US-20100016365-A1 | SUBSTITUTED 4-AMINO-PIPERIDINES | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-01-21 | — | — | US | disclosed |
| US-20090149399-A1 | HETEROCYCLIC KINASE INHIBITORS | CONCERT PHARMACEUTICALS INC. (US) | 2009-06-11 | — | — | US | disclosed |